Asset Management One’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
64,100
-3,353
-5% -$618K 0.03% 408
2025
Q4
$11.9M Sell
67,453
-454
-0.7% -$74.2K 0.03% 415
2025
Q3
$9.51M Buy
67,907
+5,097
+8% +$689K 0.03% 472
2025
Q2
$7.89M Buy
62,810
+1,390
+2% +$173K 0.02% 506
2025
Q1
$8.4M Buy
61,420
+3,194
+5% +$457K 0.03% 469
2024
Q4
$8.81M Buy
58,226
+2,871
+5% +$484K 0.03% 457
2024
Q3
$10.7M Buy
55,355
+324
+0.6% +$67.8K 0.04% 411
2024
Q2
$12.8M Sell
55,031
-3,879
-7% -$843K 0.05% 346
2024
Q1
$12.7M Sell
58,910
-2,347
-4% -$550K 0.05% 363
2023
Q4
$16M Sell
61,257
-2,386
-4% -$586K 0.06% 299
2023
Q3
$16.4M Buy
63,643
+3,788
+6% +$1.01M 0.07% 272
2023
Q2
$17M Buy
59,855
+1,498
+3% +$446K 0.07% 274
2023
Q1
$16.2M Buy
58,357
+27
+0% +$7.47K 0.07% 282
2022
Q4
$16.1M Sell
58,330
-3,010
-5% -$850K 0.08% 269
2022
Q3
$16.4M Sell
61,340
-1,227
-2% -$261K 0.08% 248
2022
Q2
$12.8M Sell
62,567
-440
-0.7% -$89.9K 0.06% 328
2022
Q1
$13.3M Sell
63,007
-3,634
-5% -$790K 0.05% 371
2021
Q4
$17.2M Sell
66,641
-1,378
-2% -$354K 0.06% 333
2021
Q3
$19.2M Sell
68,019
-2,795
-4% -$916K 0.07% 277
2021
Q2
$24.5M Sell
70,814
-1,446
-2% -$438K 0.09% 223
2021
Q1
$20.2M Sell
72,260
-7,905
-10% -$2.13M 0.08% 247
2020
Q4
$19.5M Sell
80,165
-6,027
-7% -$1.55M 0.08% 249
2020
Q3
$24.5M Sell
86,192
-7,391
-8% -$2.06M 0.11% 181
2020
Q2
$25M Sell
93,583
-3,055
-3% -$918K 0.12% 173
2020
Q1
$30.6M Sell
96,638
-14,944
-13% -$4.54M 0.18% 116
2019
Q4
$33.1M Sell
111,582
-10,931
-9% -$3.03M 0.15% 146
2019
Q3
$28.5M Buy
122,513
+11,308
+10% +$2.63M 0.14% 164
2019
Q2
$26M Buy
111,205
+8,043
+8% +$1.86M 0.13% 174
2019
Q1
$24.4M Sell
103,162
-230,965
-69% -$72.7M 0.13% 161
2018
Q4
$100M Sell
334,127
-9,771
-3% -$3.12M 0.24% 91
2018
Q3
$122M Sell
343,898
-3,254
-0.9% -$1.12M 0.25% 84
2018
Q2
$101M Sell
347,152
-18,519
-5% -$5.21M 0.22% 97
2018
Q1
$100M Buy
365,671
+8,778
+2% +$2.72M 0.23% 97
2017
Q4
$114M Sell
356,893
-5,673
-2% -$1.82M 0.25% 85
2017
Q3
$113M Sell
362,566
-4,795
-1% -$1.42M 0.27% 83
2017
Q2
$99.7M Buy
367,361
+7,049
+2% +$1.86M 0.25% 93
2017
Q1
$98.4M Sell
360,312
-10,357
-3% -$2.93M 0.26% 84
2016
Q4
$105M Buy
370,669
+303,776
+454% +$90M 0.27% 81
2016
Q3
$20.5M Sell
66,893
-12,454
-16% -$3.69M 0.3% 72
2016
Q2
$19M Sell
79,347
-13,728
-15% -$3.62M 0.28% 80
2016
Q1
$23.8M Sell
93,075
-7,669
-8% -$2.03M 0.35% 58
2015
Q4
$31.1M Buy
100,744
+3,483
+4% +$1M 0.46% 41
2015
Q3
$27.1M Sell
97,261
-6,148
-6% -$2.03M 0.41% 47
2015
Q2
$41M Sell
103,409
-9,457
-8% -$3.8M 0.57% 26
2015
Q1
$48.6M Buy
112,866
+4,241
+4% +$1.67M 0.6% 22
2014
Q4
$37.3M Buy
108,625
+26,812
+33% +$8.67M 0.48% 28
2014
Q3
$27M Buy
81,813
+44,767
+121% +$14.8M 0.37% 49
2014
Q2
$11.8M Sell
37,046
-2,983
-7% -$898K 0.18% 134
2014
Q1
$11.8M Sell
40,029
-3,685
-8% -$1.17M 0.19% 130
2013
Q4
$12.2M Buy
43,714
+8,032
+23% +$2.08M 0.19% 125
2013
Q3
$8.72M Sell
35,682
-22,680
-39% -$5.08M 0.13% 170
2013
Q2
$12.3M Buy
+58,362
New +$12.5M 0.2% 113

Other funds holding BIIB

Asset Management One's BIIB Position: Q1 2026 in Review

Asset Management One reduced its Biogen (BIIB) stake by 5% in Q1 2026, selling an estimated $618K and leaving 64,100 shares worth $11.8M. The position accounts for 0.03% of the portfolio, ranked #408.

Asset Management One first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Asset Management One held 64,100 shares of Biogen worth $11.8M as of Q1 2026.
  • Asset Management One sold 3,353 Biogen shares in Q1 2026, an estimated $618K.
  • Biogen made up 0.03% of Asset Management One's portfolio in Q1 2026, its #408 holding.
  • Asset Management One first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Asset Management One's Biogen position peaked at $122M in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.